UB Paderborn / Katalog / Suche / in CDI

Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer

Molecular cancer therapeutics, 2014-06, Vol.13 (6), p.1636-1644

2014

Volltextzugriff (PDF)

Abstract 2125: Roles of KAT6A and KAT6B in the biology of estrogen positive breast cancer

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2125-2125

2021

Volltextzugriff (PDF)

Abstract B2: Switching to aflibercept treatment resulted in greater tumor responses than continuous bevacizumab treatment in patient-derived xenograft models of colorectal cancer

Molecular cancer therapeutics, 2013-11, Vol.12 (11_Supplement), p.B2-B2

2013

Volltextzugriff (PDF)

Long‐term experimental drought alters floral scent and pollinator visits in a Mediterranean plant community despite overall limited impacts on plant phenotype and reproduction

The Journal of ecology, 2022-11, Vol.110 (11), p.2628-2648

2022

Volltextzugriff (PDF)

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

European journal of cancer (1990), 2017-07, Vol.79, p.158-165

2017

Volltextzugriff (PDF)

MARINE-EXPRESS: taking advantage of high throughput cloning and expression strategies for the post-genomic analysis of marine organisms

Microbial cell factories, 2010-06, Vol.9 (1), p.45-45, Article 45

2010

Volltextzugriff (PDF)

Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France

Antimicrobial Agents and Chemotherapy, 2001-02, Vol.45 (2), p.636-638

2001

Volltextzugriff (PDF)

Phenotypic and Genetic Diversity of Invasive Pneumococcal Isolates Recovered from French Children

Journal of Clinical Microbiology, 2002-08, Vol.40 (8), p.2994-2998

2002

Volltextzugriff (PDF)

FOLFIRINOX in first-line metastatic pancreatic cancer regimen (FLMPC): What profile of patients take a real advantage? Real world cohort from cancer observatory from Brittany and Pays de la Loire areas

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e15204-e15204

2014

Volltextzugriff (PDF)

Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer

Journal of clinical oncology, 2014-01, Vol.32 (3_suppl), p.305-305

2014

Volltextzugriff (PDF)

Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer

Journal of clinical oncology, 2013-02, Vol.31 (4_suppl), p.248-248

2013

Volltextzugriff (PDF)

Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections

Antimicrobial Agents and Chemotherapy, 2003-07, Vol.47 (7), p.2345-2347

2003

Volltextzugriff (PDF)

Molecular Epidemiology Survey of Penicillin-Susceptible and -Resistant Streptococcus pneumoniae Recovered from Patients with Meningitis in France

The Journal of infectious diseases, 2000-06, Vol.181 (6), p.1971-1978

2000

Volltextzugriff (PDF)

Fetal tachycardia: A role for amiodarone as first- or second-line therapy?

Archives of cardiovascular diseases, 2008-10, Vol.101 (10), p.619-627

2008

Volltextzugriff (PDF)

Mechanisms of the Spread of Penicillin Resistance in Streptococcus pneumoniae Strains Causing Meningitis in Children in France

The Journal of infectious diseases, 1996-09, Vol.174 (3), p.520-528

1996

Volltextzugriff (PDF)

Killing activities of trovafloxacin alone and in combination with β-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid

Antimicrobial agents and chemotherapy, 1999-10, Vol.43 (10), p.2372-2375

1999

Volltextzugriff (PDF)

Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis

Antimicrobial agents and chemotherapy, 1998-04, Vol.42 (4), p.942-944

1998

Volltextzugriff (PDF)

Killing Activities of Trovafloxacin Alone and in Combination with β-Lactam Agents, Rifampin, or Vancomycin againstStreptococcus pneumoniae Isolates with Various Susceptibilities to Extended-Spectrum Cephalosporins at Concentrations Clinically Achievable in Cerebrospinal Fluid

Antimicrobial Agents and Chemotherapy, 1999-10, Vol.43 (10), p.2372-2375

1999

Volltextzugriff (PDF)

Emergence in France of Multiple Clones of ClinicalStreptococcus pneumoniae Isolates with High-Level Resistance to Amoxicillin

Antimicrobial Agents and Chemotherapy, 1999-06, Vol.43 (6), p.1480-1483

1999

Volltextzugriff (PDF)

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis

Antimicrobial Agents and Chemotherapy, 1998-04, Vol.42 (4), p.942-944

1998

Volltextzugriff (PDF)

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniae Isolates from Children with Meningitis

Antimicrobial agents and chemotherapy, 1998-08, Vol.42 (8), p.2152-2152

1998

Volltextzugriff (PDF)

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis

Antimicrobial agents and chemotherapy, 1998-08, Vol.42 (8), p.2152-2152

1998

Volltextzugriff (PDF)

Les cultures des sciences en Europe

Questions de communication (Nancy), 2010

2010

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer

Abstract 2125: Roles of KAT6A and KAT6B in the biology of estrogen positive breast cancer

Abstract B2: Switching to aflibercept treatment resulted in greater tumor responses than continuous bevacizumab treatment in patient-derived xenograft models of colorectal cancer

Long‐term experimental drought alters floral scent and pollinator visits in a Mediterranean plant community despite overall limited impacts on plant phenotype and reproduction

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

MARINE-EXPRESS: taking advantage of high throughput cloning and expression strategies for the post-genomic analysis of marine organisms

Mechanisms of Macrolide Resistance in Clinical Pneumococcal Isolates in France

Phenotypic and Genetic Diversity of Invasive Pneumococcal Isolates Recovered from French Children

FOLFIRINOX in first-line metastatic pancreatic cancer regimen (FLMPC): What profile of patients take a real advantage? Real world cohort from cancer observatory from Brittany and Pays de la Loire areas

Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer

Efficacy and safety of FOLFIRINOX in patients with pancreatic metastatic cancer

Activity of Telithromycin against Penicillin-Resistant Streptococcus pneumoniae Isolates Recovered from French Children with Invasive and Noninvasive Infections

Molecular Epidemiology Survey of Penicillin-Susceptible and -Resistant Streptococcus pneumoniae Recovered from Patients with Meningitis in France

Fetal tachycardia: A role for amiodarone as first- or second-line therapy?

Mechanisms of the Spread of Penicillin Resistance in Streptococcus pneumoniae Strains Causing Meningitis in Children in France

Killing activities of trovafloxacin alone and in combination with β-lactam agents, rifampin, or vancomycin against Streptococcus pneumoniae isolates with various susceptibilities to extended-spectrum cephalosporins at concentrations clinically achievable in cerebrospinal fluid

Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis

Killing Activities of Trovafloxacin Alone and in Combination with β-Lactam Agents, Rifampin, or Vancomycin againstStreptococcus pneumoniae Isolates with Various Susceptibilities to Extended-Spectrum Cephalosporins at Concentrations Clinically Achievable in Cerebrospinal Fluid

Emergence in France of Multiple Clones of ClinicalStreptococcus pneumoniae Isolates with High-Level Resistance to Amoxicillin

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniae Isolates from Children with Meningitis

Comparative In Vitro Killing Activities of Meropenem, Imipenem, Ceftriaxone, and Ceftriaxone plus Vancomycin at Clinically Achievable Cerebrospinal Fluid Concentrations against Penicillin-Resistant Streptococcus pneumoniaeIsolates from Children with Meningitis

Les cultures des sciences en Europe

Suchergebnisse filtern